Drug Shortage Report for CYTOGAM

Last updated on 2023-12-10 History
Report ID 185788
Drug Identification Number 02231962
Brand name CYTOGAM
Common or Proper name CYTOMEGALOVIRUS IMMUNE GLOBULIN (HUMAN)
Company Name KI BIOPHARMA LLC
Market Status MARKETED
Active Ingredient(s) CYTOMEGALOVIRUS IMMUNOLOBULIN
Strength(s) 2500MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 ML
ATC code J06BB
ATC description IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2023-06-15
Actual start date
Estimated end date 2024-01-15
Actual end date 2023-12-07
Shortage status Resolved
Updated date 2023-12-10
Company comments Technology Transfer from CSL to Kamada
Health Canada comments
Tier 3 Status No
Contact Address 3 GERMAY DR, UNIT 4 #1302
WILMINGTON, DELAWARE
UNITED STATES 19804
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-03-01 English Compare
v2 2023-03-01 French Compare
v3 2023-06-16 English Compare
v4 2023-12-10 English Compare
v5 2023-12-10 French Compare

Showing 1 to 5 of 5